Que-related treatments resulted in pronounced reductions in IL-6 and TNF-α, as well as increases in IL-10, suggesting a potent suppression of inflammation, which was critical to alleviating the inflammatory burden in COPD. The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.